Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
{{output}}
Background: Allergic bronchopulmonary aspergillosis (ABPA) is a condition characterized by a Th2 response, serum eosinophilia, and increased total serum IgE to Aspergillus fumigatus. ABPA occurs in cystic fibrosis (CF) and asthma... ...
